MAR heads into the post-earnings session carrying a cleaner story than the setup suggested — a beat on both lines and raised full-year guidance, all delivered against a backdrop of unusual options defensiveness this week.
Q1 results landed ahead of the bell on May 6. Adjusted EPS came in at $2.72, clearing the $2.55 consensus by a meaningful margin. Revenue of $6.65 billion beat estimates of $6.59 billion. For the full year, management guided adjusted EPS to a range of $11.38–$11.63, bracketing the $11.60 Street estimate. The company also noted that global RevPAR strength is offsetting pressure from Middle East conflict — a nuance that matters for how investors frame the international growth story. Q2 guidance of $2.99–$3.06 came in fractionally below the $3.06 estimate, handing bears one data point worth watching.
Options traders were not positioned for an upside print. The put/call ratio climbed to 0.54 this week, nearly two standard deviations above its 20-day average of 0.45 — the most defensive reading in several months. That hedging pressure built up precisely as the earnings date approached, a pattern consistent with investors buying downside protection rather than expressing a directional view. With the print now out and the number beating on the top and bottom lines, much of that defensive positioning looks set to unwind. The 2% gain on May 5 — the day before results — already suggested some positioning relief was beginning.
The Street had been quietly ratcheting targets higher going into earnings. Evercore ISI raised its target to $400 while maintaining Outperform. JPMorgan lifted to $383 and Barclays to $372, both keeping Neutral-equivalent ratings. The direction of travel was broadly constructive, with the mean target now at $372.67 against a close of $354.52 — implying around 5% upside. The tension between bullish target upgrades and neutral ratings captures the Street's core dilemma: Marriott's asset-light model, 30-brand portfolio, and strong cash generation are well understood, but a trailing PE of 29x against expected EBITDA growth of roughly 8% annually leaves little room for execution misses. The EV/EBITDA multiple has expanded meaningfully over the past month, rising to 18.3x — the highest level in the 30-day window.
Short interest is not a primary angle this week. At 2.1% of the free float, and down roughly 13% over the past month, short positioning has been retreating steadily since early April — when it peaked near 6.6 million shares around the April 8–9 tariff volatility spike. The borrow market reflects zero urgency: cost to borrow is barely above 0.43%, and availability is loose. The ORTEX short score of 34.7 is roughly mid-range. Nothing in the lending data suggests any squeeze dynamic or meaningful incremental conviction from the bear camp.
What to watch now is whether the Q2 guide — slightly below the $3.06 consensus — generates any downward target revisions from the neutral-rated houses, and how management's Middle East commentary shapes sentiment around the international RevPAR trajectory heading into the summer travel season.
See the live data behind this article on ORTEX.
Open MAR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
